Controversies and Challenges in Elective Orthopedic Surgery in Patients With Hemophilia and Inhibitors

Seminars in Hematology

Volumn 45, Issue SUPPL. 1, 2008, Pages

  Jiménez Yuste, Victor ^a,b   Rodriguez Merchan, E Carlos ^a,b   Alvarez, Maria Teresa ^b   Quintana, Manuel ^b   Fernandez, Ihosvany ^b   Hernandez Navarro, Fernando ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANALGESIA; ANESTHESIA; ARTICLE; BLEEDING; HEMATOMA; HEMOPHILIA; HUMAN; ORTHOPEDIC SURGERY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REHABILITATION CARE; RISK FACTOR; TREATMENT INDICATION;

BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; FACTOR VIIA; HEMOPHILIA A; HUMANS; JOINT DEFORMITIES, ACQUIRED; ORTHOPEDIC PROCEDURES; RECOMBINANT PROTEINS; SURGICAL PROCEDURES, ELECTIVE;

EID: 44649113635     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2008.03.009     Document Type: Article

References (26)

1. Manco-Johnson M.J., Abshire T.C., Shapiro A.D., Riske B., Hacker M.R., Kilcoyne R., et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 357 (2007) 535-544
2. Wight J., and Paisley S. The epidemiology of inhibitors in haemophilia A: A systematic review. Haemophilia 9 (2003) 418-435
3. Berntorp E., Shapiro A., Astermark J., Blanchette V.S., Collins P.W., Dimichele D., et al. Inhibitor treatment in haemophilias A and B: Summary statement for the 2006 international consensus conference. Haemophilia 12 suppl 6 (2006) 1-7
4. Leissinger C.A. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction. Am J Hematol 77 (2004) 187-193
5. Soucie J.M., Cianfrini C., Janco R.L., Kulkarni R., Hambleton J., Evatt B., et al. Joint range-of-motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 103 (2004) 2467-2473
6. Gringeri A., Mantovani L.G., Scalone L., Mannucci P.M., and The COCIS Study Group. COCIS Study Group: Cost of care and quality of life for patients with hemophilia complicated by inhibitors. Blood 102 (2003) 2358-2363
7. Rodriguez-Merchan E.C., Wiedel Jd J., Wallny T., Caviglia H., Hvid I., Berntorp E., et al. Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities. Semin Hematol 41 suppl 1 (2004) 109-116
8. Aledort L.M., Haschmeyer R.H., Pettersson H., and The Orthopaedic Outcome Study Group. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 236 (1994) 391-399
9. Aznar J.A., Magallón M., Querol F., Gorina E., and Tusell J.M. The orthopaedic status of severe haemophiliacs in Spain. Haemophilia 6 (2000) 170-176
10. Morfini M., Haya S., Tagariello G., Pollmann H., Quintana M., Siegmund B., et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 13 (2007) 606-612
11. Scalone L., Mantovani L.G., Mannucci P.M., Gringeri A., and The COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 12 (2006) 154-162
12. Ludlam C. Identifying and managing inhibitor patients requiring orthopaedic surgery-The multidisciplinary team approach. Haemophilia 11 suppl 1 (2005) 7-10
13. Rodriguez-Merchan E.C., Quintana M., Jimenez-Yuste V., and Hernández-Navarro F. Orthopaedic surgery for inhibitor patients: A series of 27 procedures (25 patients). Haemophilia 13 (2007) 613-619
14. Weitz J.I., Middeldorp S., Geerts W., and Heit J.A. Thrombophilia and new anticoagulant drugs. Hematology Am Soc Hematol Educ Program (2004) 424-438
15. Aledort L.M. Factor VIII inhibitor bypassing activity (FEIBA)-Addressing safety issues. Haemophilia 14 (2007) 39-43
16. Roberts H.R., Monroe III D.M., and Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 41 suppl 1 (2004) 101-108
17. Goddard N. Case studies: Orthopaedic surgery in adult patients with haemophilia A with inhibitors. Haemophilia 11 suppl 1 (2005) 32-37
18. Hay C.R., Brown S., Collins P.W., Keeling D.M., and Liesner R. The diagnosis and management of factor VIII and IX inhibitors: A guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133 (2006) 591-605
19. Gringeri A., Mannucci P.M., and Italian Association of Haemophilia Centres. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors. Haemophilia 11 (2005) 611-619
20. Pruthi R.K., Mathew P., Valentino L.A., Sumner M.J., Seremetis S., Hoots W.K., et al. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial. Thromb Haemost 98 (2007) 726-732
21. Key N.S., and Nelsestuen G.L. Views on methods for monitoring recombinant factor VIIa in inhibitor patients. Semin Hematol 41 suppl 1 (2004) 51-54
22. Sørensen B., and Ingerslev J. Tailoring haemostatic treatment to patient requirements-An update on monitoring haemostatic response using thrombelastography. Haemophilia 11 suppl 1 (2005) 1-6
23. Stephensen D. Rehabilitation of patients with haemophilia after orthopaedic surgery: A case study. Haemophilia 11 suppl 1 (2005) 26-29
24. Rodriguez-Merchan E.C., Rocino A., Ewenstein B., Bartha L., Batorova A., Goudemand J., et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: Summary statement. Haemophilia 10 suppl 2 (2004) 50-52
25. Solimeno L.P., Perfetto O.S., Pasta G., and Santagostino E. Total joint replacement in patients with inhibitors. Haemophilia 12 suppl 3 (2006) 113-116
26. Rodriguez-Merchan E.C., Wiedel J.D., Wallny T., Hvid I., Berntorp E., Rivard G.E., et al. Elective orthopaedic surgery for inhibitor patients. Haemophilia 9 (2003) 625-631